Skip to main content Skip to secondary navigation

Browse Stanford's available technologies by keyword or collection today by exploring our Techfinder Catalog.

Banner: Stanford High Impact Technology Fund Logo

Injectable hydrogels for biomedical applications

Main content start
needle injecting into cell - Credit: iStock.com/TanyaRow

Credit: iStock.com/TanyaRow

Injectable hydrogels for sustained release of agents in vaccines or cancer immunotherapy.

About the Technology

Hydrogels are an important class of biomaterial that have received much attention for controlled drug-delivery applications on account of their similarity to soft biological tissue and highly variable mechanical properties. We have developed shear-thinning injectable hydrogels where the delivery of therapeutics can be precisely controlled, enabling months-long release of entrapped cargo. These materials are readily processed and synthesized in a facile, inexpensive, and scalable manner, which are distinguishing features for many important biomedical applications.

The HIT Fund supported the efforts to establish the regulatory requirements and preliminary clinical pathways for the priority indications.  

Team Members

Photo of Eric Appel

Eric Appel

Associate Professor of Materials Science and Engineering, Senior Fellow at the Woods Institute for the Environment and Associate Professor, by courtesy, of Pediatrics (Endocrinology) and of Bioengineering

View Stanford Profile

Press

Eric Appel. Engineering is fundamentally about solving problems. Stanford Report (April 17, 2025).

Eric Appel: Gels are changing the face of engineering ... and medicine. The Future of Everything Podcast (October 4, 2021).

Related Web Links

Supramolecular (bio)materials (Dr. Appel's Lab Website)